• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS CREATININE PLUS VER.2; ENZYMATIC METHOD, CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS CREATININE PLUS VER.2; ENZYMATIC METHOD, CREATININE Back to Search Results
Model Number CREP G2
Device Problems High Test Results (2457); Insufficient Information (3190)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/28/2021
Event Type  malfunction  
Manufacturer Narrative
Unique identifier (udi) # (b)(4).The last calibration was performed on (b)(6) 2021.Calibration and qc were within specification.The alarm trace and pre-analytical sample handling details were requested, but not provided.The field service representative verified alignments and made adjustments, inspected probes and seals, and performed a precision test for creatinine with results within specifications.The investigation did not identify a product problem.The cause of the event could not be determined.
 
Event Description
The initial reporter received questionable creatinine plus ver.2 results for one (1) patient sample on a cobas 8000 c701 module, serial number (b)(4).The initial result was 3.67 mg/dl.Reagent lot number 53373401 was used to obtain the result.The initial result was reported to the patient's provider, who ordered additional blood tests and a new sample was drawn.The result from the new sample was (b)(6) so the initial sample was retested.A numerical value for the result from the second sample was not provided.The repeat result from the initial sample was 0.78 mg/dl and was obtained on a different c701 analyzer.This result was deemed correct.The reagent lot number and expiration date that was used to obtain the result is unknown.The initial sample was repeated again and the result was 0.87 mg/dl.This result was obtained on the same analyzer that was used to obtain the initial result.Reagent lot number 53663901 with an expiration date of 30-nov-2021 was used to obtain the result of 0.87 mg/dl.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CREATININE PLUS VER.2
Type of Device
ENZYMATIC METHOD, CREATININE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key11885096
MDR Text Key252791705
Report Number1823260-2021-01569
Device Sequence Number1
Product Code JFY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K024098
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 05/26/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/26/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2021
Device Model NumberCREP G2
Device Catalogue Number05168589190
Device Lot Number53373401
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/05/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age36 YR
-
-